... Inc. purchased a new position in shares of CymaBay Therapeutics during the 4th quarter worth about $115,000. Ardsley Advisory Partners boosted its stake in shares of CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory Partners now ...
https://sportsperspectives.com/2018/01/28/cymabay-therapeutics-inc-cbay-director-sells-480354-84-in-stock.html
No comments:
Post a Comment